首页 News 正文

According to the AI news, the US stock market of Bristol Myers Squibb rose more than 5% before trading. The US regulatory authorities approved its Cobenfy for the treatment of schizophrenia, which is the first drug approved for the treatment of schizophrenia in decades.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

胡胡胡美丽_ss 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    34